- Novel Ghrelin Antagonists for treatment of Obesity.
- Novel Sigma-1 Receptor Agonists for treatment of Neurodegenerative Diseases.
- Novel A2A Adenosine Receptor Antagonists for the Treatment of Parkinson’s disease and SAR of the new Preladenant analogs.
- Discovery of novel Excitatory Amino Acid Transporter-2 (EAAT2) modulators for the treatment of ALS and other neurodegenerative disorders.
- Regulation of cancer cell metabolism: Targeting cancer metabolism as an alternative therapeutic treatment. (From natural products chemistry to drug discovery).
- Novel therapeutic agents for treatment of diabetes (T2DM).
- Process development of novel therapeutic agents; cost effective and green chemistry applications for drug discovery.
- Fluorinated novel VEGF inhibitors for cancer treatment.
Call us : +90-216-681-5363